H

Humedix Co Ltd
KOSDAQ:200670

Watchlist Manager
Humedix Co Ltd
KOSDAQ:200670
Watchlist
Price: 45 250 KRW 7.74% Market Closed
Market Cap: 466.5B KRW
Have any thoughts about
Humedix Co Ltd?
Write Note

Humedix Co Ltd
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Humedix Co Ltd
Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
H
Humedix Co Ltd
KOSDAQ:200670
Long-Term Debt
â‚©1.8B
CAGR 3-Years
90%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Long-Term Debt
â‚©127.2B
CAGR 3-Years
34%
CAGR 5-Years
12%
CAGR 10-Years
14%
SK Biopharmaceuticals Co Ltd
KRX:326030
Long-Term Debt
â‚©121B
CAGR 3-Years
107%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Long-Term Debt
â‚©97.9B
CAGR 3-Years
-31%
CAGR 5-Years
-28%
CAGR 10-Years
-8%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Long-Term Debt
â‚©36.4B
CAGR 3-Years
8%
CAGR 5-Years
37%
CAGR 10-Years
N/A
C
Celltrion Pharm Inc
KOSDAQ:068760
Long-Term Debt
â‚©15.6B
CAGR 3-Years
-29%
CAGR 5-Years
-17%
CAGR 10-Years
-19%
No Stocks Found

Humedix Co Ltd
Glance View

Market Cap
470.4B KRW
Industry
Pharmaceuticals

Humedix Co., Ltd. engages in the manufacture and sale of hyaluronic acid based medical devices and arthritis treatment products. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2014-12-26. The firm distributes its products within domestic market and to overseas markets

Intrinsic Value
63 395.66 KRW
Undervaluation 29%
Intrinsic Value
Price
H

See Also

What is Humedix Co Ltd's Long-Term Debt?
Long-Term Debt
1.8B KRW

Based on the financial report for Sep 30, 2024, Humedix Co Ltd's Long-Term Debt amounts to 1.8B KRW.

What is Humedix Co Ltd's Long-Term Debt growth rate?
Long-Term Debt CAGR 3Y
90%

Over the last year, the Long-Term Debt growth was -33%. The average annual Long-Term Debt growth rates for Humedix Co Ltd have been 90% over the past three years .

Back to Top